One Health Group’s Chairman Derek Bickerstaff outlines another period of strong growth — with patient referrals, surgeons, and capacity all sharply higher...
Verge Technologies’ Jimmy Jobe reveals how AI-powered, self-healing database systems are eliminating the fragility of single-cloud dependence. With SentientDB at its core, Verge is building a future where enterprise data never goes dark...
RECI offers something rare: liquid access to a booming but illiquid market. Harman & Co’s Mark Thomas explains how this unique real estate credit investor continues to provide strong returns through macro turbulence—with a model that hasn’t flinched in six years...
AW1 is more than just a battery project. David Taaffe explains how Ampeak Energy’s flagship development has triggered a domino effect across its multi-GWh pipeline — paving the way for £100 million in future annual revenues...
Cizzle Biotechnology is now in commercial motion, with its lung cancer diagnostic test entering clinical validation across North America. Backed by Cizzle Bio, OmniHealth, and the Moffitt Cancer Center, the company is moving from lab bench to nationwide rollout — with royalty payments already in hand...
EDX Medical Group Plc has joined forces with leading NHS and government health bodies to deliver a rapid hospital-acquired pneumonia test. Sir Chris Evans explains why this partnership could change patient outcomes, cut costs, and accelerate the UK’s precision medicine agenda...
EDX Medical will partner with the Intensive Care Unit at Cambridge University Hospitals NHS Foundation Trust to support the further advancement of a highly precise test that identifies the DNA or RNA of the microbes that cause lung infection in critically ill patients...
CEO Andrew Hume walks us through a significant new agreement with Metals One, a deal that brings in capital and specialist partners while allowing Thor to retain upside exposure..
Stephane Foucaud of Auctus Advisors reveals how robust execution and a cash-rich balance sheet are fuelling both growth and shareholder value. Investors should keep Valeura firmly on their radar...
The trust delivered an exceptional share price performance of +9.9%. This significantly outperformed both the NAV growth (+3.8%) and the FTSE All-World Index (+4.8%)...
New Frontier Minerals has released an expanded suite of preliminary metallurgical results at its Big One Deposit, validating its fast-track production strategy..
Hercules Plc CEO Brusk Korkmaz and CFO Paul Wheatcroft break down their acquisition of Advantage NRG Ltd., explaining why this move anchors the company firmly in the UK’s infrastructure surge..
Leveraging the Prime Oil & Gas amalgamation, the company has doubled its reserves and production base, enabling it to triple its base dividend per share..
One Health Group’s Chairman Derek Bickerstaff outlines another period of strong growth — with patient referrals, surgeons, and capacity all sharply higher...
Verge Technologies’ Jimmy Jobe reveals how AI-powered, self-healing database systems are eliminating the fragility of single-cloud dependence. With SentientDB at its core, Verge is building a future where enterprise data never goes dark...
RECI offers something rare: liquid access to a booming but illiquid market. Harman & Co’s Mark Thomas explains how this unique real estate credit investor continues to provide strong returns through macro turbulence—with a model that hasn’t flinched in six years...
AW1 is more than just a battery project. David Taaffe explains how Ampeak Energy’s flagship development has triggered a domino effect across its multi-GWh pipeline — paving the way for £100 million in future annual revenues...
Cizzle Biotechnology is now in commercial motion, with its lung cancer diagnostic test entering clinical validation across North America. Backed by Cizzle Bio, OmniHealth, and the Moffitt Cancer Center, the company is moving from lab bench to nationwide rollout — with royalty payments already in hand...
EDX Medical Group Plc has joined forces with leading NHS and government health bodies to deliver a rapid hospital-acquired pneumonia test. Sir Chris Evans explains why this partnership could change patient outcomes, cut costs, and accelerate the UK’s precision medicine agenda...
EDX Medical will partner with the Intensive Care Unit at Cambridge University Hospitals NHS Foundation Trust to support the further advancement of a highly precise test that identifies the DNA or RNA of the microbes that cause lung infection in critically ill patients...
CEO Andrew Hume walks us through a significant new agreement with Metals One, a deal that brings in capital and specialist partners while allowing Thor to retain upside exposure..
Stephane Foucaud of Auctus Advisors reveals how robust execution and a cash-rich balance sheet are fuelling both growth and shareholder value. Investors should keep Valeura firmly on their radar...
The trust delivered an exceptional share price performance of +9.9%. This significantly outperformed both the NAV growth (+3.8%) and the FTSE All-World Index (+4.8%)...
New Frontier Minerals has released an expanded suite of preliminary metallurgical results at its Big One Deposit, validating its fast-track production strategy..
Hercules Plc CEO Brusk Korkmaz and CFO Paul Wheatcroft break down their acquisition of Advantage NRG Ltd., explaining why this move anchors the company firmly in the UK’s infrastructure surge..
Leveraging the Prime Oil & Gas amalgamation, the company has doubled its reserves and production base, enabling it to triple its base dividend per share..
